Disruptive Pharma to attend CPHI Milan 2026

Disruptive Pharma will attend CPHI Milan on 6–8 October, one of the pharmaceutical industry’s leading global events, bringing together companies from across the pharma value chain.

Peter Åsberg, CEO of Disruptive Pharma, will be at CPHI to meet with current and potential partners and discuss opportunities around Formulite®, our formulation platform for poorly soluble and other challenging compounds in oral drug development.

With a growing number of partner projects and dialogues, and an increasing focus on development, scale-up and manufacturing, CPHI provides an important opportunity to connect with pharmaceutical and biotechnology companies, CDMOs and other industry partners. We look forward to discussing oral drug development, formulation challenges and how Formulite® can help improve drug product performance, streamline manufacturing and enable the development of more effective and patient-friendly oral medicines.

Interested in learning more about Formulite® or discussing a potential project? Reach out to our commercial team to start a conversation — at CPHI or beyond.